Back to results
US 2006/0052368 A1Published application
Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
OwnerGlen Ernst, Eifion Phillips +1inventors
InventorsGlen Ernst, Eifion Phillips, Richard Schmiesing
Life of this patent
Estimating the term…
Abstract
Nicotinic acetylcholine receptor agonists of formula I wherein a, b, c, D and R are as defined in the specification, enantiomers, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
Claims12
A compound of formula I:
- wherein:
- a, b and c are each 1 or 2;
- D is oxygen or sulfur, and
- R is selected from moieties of formulae II, III or IV:
- wherein
- R1, and R2 are independently selected from hydrogen, CN, CF3, halogen, C1-4alkyl, C2-4alkenyl, C2-4alkynyl or CO2R3;
- Ar is phenyl, or
- Ar is a 5- or 6-membered aromatic heterocyclic moiety having 1, 2 or 3 heteroatoms selected from nitrogen, oxygen or sulfur where not more than one of said heteroatoms is oxygen or sulfur, or
- Ar is an 8-, 9- or 10-membered fused aromatic heterocyclic moiety having 1, 2 or 3 heteroatoms selected from nitrogen, oxygen or sulfur where not more than one of said heteroatoms is oxygen or sulfur, or
- Ar is an 8-, 9- or 10-membered aromatic carbocyclic ring,
- wherein said phenyl, heterocyclic rings or carbocyclic rings have 0, 1 or more substituents independently selected from hydrogen, CN, NO2, CF3, halogen, C1-4alkyl, C2-4alkenyl, C2-4alkynyl, aryl, heteroaryl, OR3, CO2R3 or NR3R4;
- where
- R3 and R4 are independently at each occurrence selected from hydrogen, C1-4alkyl, aryl, heteroaryl, C(O)R5, C(O)NHR5, CO2R5, SO2R6, or
- R3, R4 and N in combination in the substituent —NR3R4 is (CH2)jQ(CH2)k where Q is O, S, NR5, or a bond;
- j is 2, 3 or 4 and k is 0, 1 or 2;
- wherein
- R5 at each occurrence is independently selected from hydrogen, C1-4alkyl, aryl, or heteroaryl, and
- R6 at each occurrence is independently selected from C1-4alkyl, aryl, or heteroaryl;
- or an enantiomer or pharmaceutically-acceptable salt thereof.
16 more elements
10-12. (canceled)
Dependencies are inferred from the claim text.